Tsu Hsien Wang on Muck Rack

Tsu Hsien Wang

As seen in: BMJ Open Respiratory Research, ersnet.org
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Tsu Hsien

Contact Tsu Hsien, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Pulmonary outcomes of incretin-based therapies in COPD patients receiving single-inhaler triple therapy

|
By Nutchapon Xanthavanij, Tsu Hsien Wang, Yu-Che Lee, Tze Ern Ong
| ersnet.org
Introduction COPD is one of the leading causes of death worldwide and poses a significant healthcare burden due to exacerbations, mortality and associated pulmonary comorbidities [1].
Open in Who Shared Issue with article?

Impact of different corticosteroids on severe community-acquired pneumonia: a systematic review and meta-analysis

|
By Yu-Cheng Chang, Weitao Liu, Tsu Hsien Wang, Juien Lo
| BMJ Open Respiratory Research Verified
Discussion In this updated meta-analysis of 10 studies comprising 1962 patients, the use of corticosteroids results in a reduction in overall mortality in patients with severe CAP. In particular, hydrocortisone reduces the risk of all-cause mortality. These clinical benefits were not observed for other types of corticosteroids.
Open in Who Shared View Duplicates (2) Issue with article?

Impact of different corticosteroids on severe community-acquired pneumonia: a systematic review and meta-analysis

|
By Tsu Hsien Wang, Yu-Cheng Chang, Juien Lo, Weitao Liu
| BMJ Open Respiratory Research Verified
Corticosteroids may provide mortality benefits in patients hospitalised for severe community-acquired pneumonia. Hydrocortisone, but not other corticosteroids, are associated with mortality benefits in patients hospitalised for severe community-acquired pneumonia. Hydrocortisone may be used to treat patients hospitalised for severe community-acquired pneumonia.
Open in Who Shared Issue with article?
See all 4 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified